Integrity, diligence, dedication to excellence, creativity and an entrepreneurial spirit are the guiding principles that I follow every day to help achieve successful outcomes for my clients.
Julian advises shareholders, management teams and financial sponsors on complex private and public mergers and acquisitions (M&A) transactions in the global healthcare sector. He has extensive experience in sell-side and buy-side transactions within the healthcare services, medical technology, healthcare information technology, pharmaceuticals and dental sectors.
Julian is passionate about working with exceptional people, truly understanding his client’s needs and goals, their businesses and underlying market dynamics within the rapidly changing global healthcare ecosystem.
Prior to joining Lincoln, Julian worked in the healthcare M&A practice at Raymond James. Previously, he worked at Richmond Park Partners, focused in M&A, and in the investment banking department at Bank of America Merrill Lynch and Berenberg.
Julian earned a Bachelor of Science in business administration from the University of Bamberg.
Recent Transactions in Healthcare
Lincoln International is pleased to announce that it served as the exclusive financial advisor to Alva-Amco Pharmacal in its sale to Kobayashi Pharmaceutical Co., Ltd. (TSE:4967)
Lincoln International is pleased to announce that Choice Health Insurance, LLC, a fully integrated consumer acquisition platform specializing in the high-growth, Medicare Advantage marketplace, has been acquired by Alight Solutions, a portfolio company of Blackstone
Lincoln International is pleased to announce that UAS Laboratories LLC, a portfolio company of Lakeview Equity Partners, LLC, has been sold to Chr. Hansen Holding A/S (CPSE:CHR), a leading, global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries
Lincoln International is pleased to announce that it has advised Doppel Farmaceutici, a portfolio company of Trilantic Europe, on the financing of its acquisition of Dietopack
Lincoln International is pleased to announce that The Araz Group, Inc. (d/b/a HealthEZ) has received an investment from Abry Partners LP
Lincoln International advised Gruppo Sapio on the acquisition of a majority stake in Homeperf from Parquest Capital; BNP Paribas Développement and Arkea Capital will reinvest in the business alongside Sapio
Lincoln International is pleased to announce that it has advised IntegriChain, Inc. on the acquisition of the life sciences division of Cumberland
Lincoln International is pleased to announce the sale of substantially all of the operating assets of Valeritas Holdings, Inc. (NASDAQ:VLRX) pursuant to Section 363 of the U.S. Bankruptcy Code to Zealand Pharma A/S (NASDAQ:ZEAL)